Health Canada on Thursday approved another respiratory syncytial virus (RSV) vaccine for adults over 60 and pregnant women. According to the ministry, pregnant women between 32 and 36 weeks of gestation can receive Pfizer's bivalent RSV vaccine, Abrysvo. to use The vaccine is also approved for Canadians over the age of 60. Vaccines are an effective tool for disease prevention and can help reduce pressure on the health care system and professionals, including nurses, doctors and frontline workers.

This is the second RSV vaccine approved by Health Canada. The first vaccine, GSK's Arexvy, was approved on August 4, 2023, but was only approved for adults over 60 years of age.

news source